These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35350098)

  • 21. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
    Singh S; Rushakoff RJ; Neinstein AB
    J Diabetes Sci Technol; 2019 May; 13(3):605-606. PubMed ID: 30931610
    [No Abstract]   [Full Text] [Related]  

  • 23. Audit of diabetic ketoacidosis management at a tertiary hospital in Johannesburg, South Africa.
    Thomas S; Mohamed NA; Bhana S
    S Afr Med J; 2019 May; 109(6):407-411. PubMed ID: 31266558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type III Hypersensitivity Reaction to Subcutaneous Insulin Preparations in a Type 1 Diabetic.
    Murray BR; Jewell JR; Jackson KJ; Agboola O; Alexander BR; Sharma P
    J Gen Intern Med; 2017 Jul; 32(7):841-845. PubMed ID: 28337685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of omalizumab in insulin hypersensitivity: a case report and review of the literature.
    Mishra S; Connors L; Tugwell B
    Diabet Med; 2018 May; 35(5):663-666. PubMed ID: 29381818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of diabetic ketoacidosis management in the medical intensive care unit after order set implementation.
    Laliberte B; Yeung SYA; Gonzales JP
    Int J Pharm Pract; 2017 Jun; 25(3):238-243. PubMed ID: 28338247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unified Hyperglycemia and Diabetic ketoacidosis (DKA) insulin infusion protocol based on an Excel algorithm and implemented via Electronic Medical Record (EMR) in Intensive Care Units.
    Gupta D; Kirn M; Jamkhana ZA; Lee R; Albert SG; Rollins KM
    Diabetes Metab Syndr; 2017; 11(4):265-271. PubMed ID: 27658894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New technology, new errors: how to prime an upgrade of an insulin infusion pump.
    Rule AM; Drincic A; Galt KA
    Jt Comm J Qual Patient Saf; 2007 Mar; 33(3):155-62. PubMed ID: 17425237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting insulin allergy in a diabetic child.
    Mastrorilli C; Rizzuti L; Cangelosi AM; Iovane B; Chiari G; Caffarelli C
    Int J Immunopathol Pharmacol; 2017 Jun; 30(2):174-177. PubMed ID: 28368217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use.
    Hanas R; Lindgren F; Lindblad B
    Pediatr Diabetes; 2009 Feb; 10(1):33-7. PubMed ID: 18761647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
    Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
    Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Severe Case of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus Associated with Anti-Glutamic Acid Decarboxylase Antibodies Following Immunotherapy with Pembrolizumab.
    Kedzior SK; Jacknin G; Hudler A; Mueller SW; Kiser TH
    Am J Case Rep; 2021 Jun; 22():e931702. PubMed ID: 34185763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic lipemia with maturity-onset diabetes of the young.
    Kadota-Shinozaki A; Nakamura T; Hidaka H; Kojima H; Yasuda H; Kashiwagi A; Kikkawa R
    Intern Med; 1997 Aug; 36(8):571-4. PubMed ID: 9260775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixed-rate insulin for adult diabetic ketoacidosis is associated with more frequent hypoglycaemia than rate-reduction method: a retrospective cohort study.
    Lorenson JL; Cusumano MC; Stewart AM; Buhnerkempe MG; Sanghavi D
    Int J Pharm Pract; 2019 Aug; 27(4):380-385. PubMed ID: 30847977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When Serum C-Peptide Measurement Drives Adequate Diabetes Mellitus Diagnosis and Therapy: A Case Report.
    Lisco G; Volpe S; Triggiani D; Triggiani V; Piazzolla G
    Endocr Metab Immune Disord Drug Targets; 2023; 23(7):1005-1009. PubMed ID: 36717991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care.
    Realsen J; Goettle H; Chase HP
    Diabetes Technol Ther; 2012 Dec; 14(12):1149-54. PubMed ID: 23009106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults.
    Westphal SA
    Am J Med; 1996 Jul; 101(1):19-24. PubMed ID: 8686710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A project identifying potential risk factors leading to diabetic ketoacidosis in patients with type 1 diabetes treated with an insulin pump.
    Caines CM; Shaw A; Solomon AM
    Clin Med (Lond); 2020 Mar; 20(2):233-234. PubMed ID: 32188670
    [No Abstract]   [Full Text] [Related]  

  • 39. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
    Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T
    J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of local delayed-type allergy to zinc-containing insulin as a cause of diabetic ketoacidosis in a patient with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion.
    Nemoto KI; Ugi S; Ogaku S; Nakaizumi N; Kato T; Fuse K; Sekine O; Morino K; Tanaka T; Maegawa H
    Diabetol Int; 2016 Dec; 7(4):447-450. PubMed ID: 30603298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.